Denmark is planning purchase or Relenza. The countries leaders are concerned about resistance to Tamiflu.http://in.reuters.com/article/rbssHealthcareNews/idINLT89242720090429
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling